Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir + Darunavir/Ritonavir in Treatment-Naive HIV-1
NCT00830804Phase 2Completed
- Start
- Apr 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raltegravir, darunavir in human immunodeficiency virus type 1 infection (HIV-1). Started Apr 2009; status: completed.
02
Drugs
raltegravirdarunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00830804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00830804.